Condition

ART

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 22 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials22

Recruiting3

Common interventions25

Lead sponsors shown15

Clinical trials

22 shown

RV630 - Approach to Control HIV With Immune Enhancement and Vaccination (ACHIEVNCT06484335 · 2025-03-27

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)NCT07263490 · 2024-10-21

Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive TechnologyNCT05625724 · 2023-08-02

Primary and Secondary Drug Resistance Mutations (DRMs) in HIV As a Risk Factor of Failure of ART, Including Two Drugs Based Regimens.NCT06661317 · 2024-11-01

Ph1 Study of FT538 Alone and With Vorinostat for Persistent Low-Level HIV ViremiaNCT05700630 · 2024-07-15

Accelerated ART Initiation for PWHIV Who Are Out of CareNCT06374758 · 2024-04-29

ACTIVE_NOT_RECRUITING

The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWHNCT06044792 · 2023-09-30

NOT_YET_RECRUITING

Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) StudyNCT06176859 · 2023-07-17

Doravirine and Weight Gain in Antiretroviral NaiveNCT05457530 · 2022-08-01

Goals for Adherence With Low-cost IncentivesNCT05378607 · 2022-04-18

ACTIVE_NOT_RECRUITING

The SMART ART StudyNCT05090150 · 2021-11-02

Investigating the Interaction Between Two Long-acting Reversible Methods of Contraception and Dolutegravir, a Treatment for HIVNCT04910711 · 2021-10-21

Strengthening Families Living With HIV in KenyaNCT04588883 · 2021-09-28

Evaluation of Secondary Distribution of HIV Self-screening Tests by Women With HIVNCT05074251 · 2021-04-20

Effects of COVID-19 on Endothelium in HIV-Positive Patients in Sub-Saharan AfricaNCT04709302 · 2021-02-01

Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSMNCT04039217 · 2019-09-30

Health in Childhood Following Assisted Reproductive TechnologyNCT03719703 · 2019-01-05

Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ARTNCT03986099 · 2018-02-01

Lotto to Link Study: A Prospective, Interventional, Randomized Study of Conditional IncentivesNCT03808194 · 2017-10-26

Effect of Zinc and Selenium Supplementation on HIV+ Individuals on Antiretroviral Treatment.NCT03421314 · 2016-09-01

Delivery Optimization for Antiretroviral Therapy (The DO ART Study)NCT02929992 · 2016-05-01

Effects of VSL#3 on Neuro-cognitive Profile of HIV PatientsNCT02276326 · 2014-07-01

Common interventions

Leading sponsors

Massachusetts General Hospital 2 Medical University of Warsaw 2 University of Washington 2 Anja Bisgaard Pinborg 1 Azienda Policlinico Umberto I 1 Biomedical Research and Training Institute, Zimbabwe 1 Botswana Harvard AIDS Institute Partnership 1 Copenhagen University Hospital, Hvidovre 1 Emory University 1 Henry M. Jackson Foundation for the Advancement of Military Medicine 1 Instituto Nacional de Enfermedades Respiratorias 1 Masonic Cancer Center, University of Minnesota 1 Medical University of Graz 1 Prism Health North Texas 1 RAND 1

Trial status mix

COMPLETED10

UNKNOWN4

RECRUITING3

ACTIVE_NOT_RECRUITING2

WITHDRAWN2

NOT_YET_RECRUITING1

Phase mix

NA10

PHASE43

PHASE12

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.